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Echocardiographic assessment of the right ventricle 
and its correlation with patient outcome in acute 
respiratory distress syndrome
Abstract 
Introduction: Acute respiratory distress syndrome (ARDS) is a life-threatening chest disease associated with a poor outcome 
and increased mortality. It may lead to pulmonary hypertension and, eventually, right ventricular failure. These changes can be 
investigated by transthoracic echocardiography (TTE) which is considered a non-invasive and cost-effective modality. We studied 
the role of right ventricular function in the prediction of the severity and mortality in ARDS. 
Material and methods: In this observational study, 94 patients suffering from ARDS were subjected to TTE to evaluate the pa-
rameters of right ventricular function by measuring tricuspid annular plane systolic excursion (TAPSE), right ventricular fractional 
area change (RV-FAC), myocardial performance index (Tei index), and systolic pulmonary artery pressure (SPAP) to assess their 
relation to the severity and mortality in ARDS. 
Results: TAPSE, SPAP, Tei index, and RV-FAC showed significant differences between survivors and non-survivors after 30 days 
(all p < 0.001). An increased length of intensive care unit stay was significantly correlated with TAPSE, Tei index, and RV-FAC (p 
= 0.002‚ 0.007‚ and 0.013, respectively). Meanwhile, the length of mechanical ventilation days was significantly correlated with 
the Tei index only (p < 0.001). Multivariate regression analysis found that TAPSE and the Tei index were independent factors 
affecting mortality (p = 0.004‚ and 0.006, respectively). RV-FAC, with a cut-off point ≤ 57%, had the highest sensitivity‚ while 
TAPSE, with a cut-off point ≤ 17 mm, had the highest specificity to predict mortality.
Conclusions: Transthoracic echocardiographic parameters of the right ventricle could be used to predict severity and mortality 
in patients with ARDS with high sensitivity and specificity. 
Key words: acute respiratory distress syndrome, transthoracic echocardiography, tricuspid annular plane systolic excursion, 
systolic pulmonary artery pressure, fractional area change
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Introduction
Acute respiratory distress syndrome (ARDS) 
is characterized by hypoxemia, non-cardiac alve-
olar edema, and diminished lung compliance [1]. 
It varies in both incidence and outcome in the 
different healthcare facilities‚ but the incidence 
of ARDS was estimated to be between 1.5–79 cas-
es per 100 000 [2]. Death rates in ARDS are still 
significant despite management plans imple-
mented by different health organizations; it was 
estimated to be between 35–45% according to an 
international observational study carried out in 
50 countries [3].
Although ARDS has circulatory complica-
tions such as hypotension, decreased cardiac 
output, myocardial infarction, and arrhythmias, 
it mainly affects the right heart [4]. The patho-
logical effect of ARDS on pulmonary vasculature 
was described more than 30 years ago by the 
term pulmonary vascular disease (PVD). This 
term delineates the functional and structural 
sequences affecting the pulmonary vasculature 
and the right ventricle (RV) in ARDS [5]. Patients 
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with PVD may progress to the severe form called 
acute cor pulmonale, which is classified as right 
ventricular dysfunction with a high mortality 
rate 60–70% [6].
Hypoxemia in ARDS is due to diffuse alveo-
lar damage and pulmonary capillary endothelial 
damage leading to increased permeability of the 
alveolocapillary membrane and influx of exudate 
into the alveoli leading to diminished lung com-
pliance [7]. Pulmonary hypertension in ARDS 
is developed by increased exudate in the alveo-
li, endothelial dysfunction with superimposed 
thrombosis in pulmonary capillaries, pulmonary 
vasoconstriction induced by hypoxemia to redis-
tribute blood flow to ventilated alveoli and limit 
ventilation perfusion mismatch, and a high PEEP 
leading to alveolar distension and an increase in 
the resistance of pulmonary vasculature [8–10]. All 
these changes lead to right ventricular failure [11].
Pulmonary vascular diseases and right-sided 
heart failure could be assessed by invasive and 
noninvasive maneuvers. Most of the research 
about the function of the RV used invasive tech-
niques such as pulmonary artery catheterization 
and transesophageal echocardiography (TEE) [12‚ 
13]. However, due to the limited use and avail-
ability of these maneuvers in the management of 
ARDS across most intensive care units (ICUs), 
a more available screening modality to evaluate 
the function of the RV in ARDS is needed [14]. 
Transthoracic echocardiography (TTE) is a nonin-
vasive and cost-effective method that can assess 
and monitor the right ventricular function [13]. 
Evaluation of the RV by TTE in ARDS could 
be done using indices such as systolic pulmonary 
artery pressure (SPAP), right ventricular fraction-
al area change (RV-FAC), tricuspid annular plane 
systolic excursion (TAPSE), and myocardial per-
formance index (MPI, Tei index) [15].
Our study aimed to identify the role of right 




We studied 94 adult patients with ARDS 
criteria according to the Berlin definition. They 
were admitted between January 2018 and March 
2019 to the Critical Care Medicine Department in 
Alexandria Main University Hospital. All patients 
were on invasive mechanical ventilation. We ex-
cluded patients who were less than 18 years old, 
had significant mitral or aortic stenosis and/or 
insufficiency, congestive heart failure, any lung 
disease that may affect the right ventricular func-
tion and pressure such as interstitial lung diseases 
and COPD, a poor echocardiographic window, 
and patients with tricuspid regurgitation. All 
patients meeting the inclusion and exclusion cri-
teria were enrolled in our study. Informed consent 
was taken from the next of kin before conducting 
the study. The study was approved by the ethics 
committee of our institution. 
Data collection
Patients included in the study were classi-
fied as survivors and non-survivors according to 
30 day mortality. Demographic data, arterial blood 
gases (ABG) just before the echocardiographic 
exam, PaO2/FiO2 ratio, Acute Physiology and 
Chronic Health Evaluation II score (APACHE II), 
ventilatory data just before the echocardiographic 
exam (PEEP, plateau pressure, driving pressure), 
days of mechanical ventilation (MV), and length 
of intensive care unit (ICU) stay were analyzed 
between both groups. Furthermore, TTE was done 
within 48 hours of ARDS diagnosis to assess 
the right ventricular function parameters which 
included TAPSE, SPAP, Tei index, and RV-FAC. 
Transthoracic echocardiographic data
The following right ventricular function 
parameters were recorded and measured us-
ing the American society of echocardiography 
2010 guidelines for right heart assessment in 
adults [15]:
1. Tricuspid annular plane systolic excursion 
(TAPSE) was obtained by placing the cursor 
of M-mode at the lateral border of the tri-
cuspid annulus and calculating the annulus 
motion longitudinally at peak systole. 
2. Right ventricular fractional area change (RV-
FAC) was obtained by making a trace along 
the endocardium of the RV in both relaxation 
and contraction phases starting at the annu-
lus, passing through apex, and ending back 
at the annulus in a four chamber view. FAC 
is calculated as (end diastolic area – end sys-
tolic area) × 100/(end diastolic area). 
3. Systolic pulmonary artery pressure (SPAP) 
can be estimated only in the presence of 
tricuspid regurgitation. The doppler signal 
of tricuspid regurgitation was estimated by 
placing the continuous wave doppler line in 
line with the tricuspid regurgitation jet. SPAP 
is calculated using the Bernoulli equation 
[4 (V)2 + right atrial pressure] where V is 
the velocity of the tricuspid regurgitation jet 
(in meters per second), and the right atrial 
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pressure is obtained from central venous 
pressure (CVP). 
4. Myocardial performance index (MPI; Tei in-
dex): Tei index is the sum of the isovolumic 
contraction and the isovolumic relaxation 
time divided by ejection time, or [(IVRT + 
IVCT)/ET]. For calculation of the Tei index, 
a pulsed tissue doppler cursor was placed 
along lateral margin of the tricuspid valve 
annulus.
Statistical analysis
Mean differences of age, pH, PaO2/FiO2 ratio, 
PaCO2, serum bicarbonate (HCO3), plateau pres-
sures, PEEP, driving pressures, APACHE II score, 
TAPSE, RV-FAC, Tei index, and SPAP between 
survivors and non-survivors were analyzed using 
the Student t-test. Days of mechanical ventilation 
and length of ICU stay were analyzed using the 
Mann Whitney test. The Chi-square test was used 
to compare between sex‚ comorbidities, and ARDS 
classification (mild-moderate-severe) in both 
groups. The correlation between (TAPSE, RV-FAC, 
Tei index, SPAP) and (PaO2/FiO2 ratio, MV days, 
length of ICU stay) was evaluated using Pearson 
coefficients. The multivariate logistic regression 
model was used to assess the effect of covariates 
on mortality. Agreement (sensitivity, specificity) 
for PaO2/FiO2 ratio, APACHE II score, and echo-
cardiographic right ventricular parameters were 
calculated to predict mortality. The results were 
analyzed using the IBM SPSS software package 
(version 20.0). Sample size calculation was done 
by the Community Medicine Department in our 
institution using Epi 7 software for sample size 
calculation. It was based on a 30% reported mor-
tality rate among ICU-admitted ARDS patients [16] 
in the Alexandria Main University Hospital which 
has an average admission of 120 patients every 
6 months (based on ICUs statistics). The minimum 
sample size required to achieve 80% study power 
and 95% confidence limits was 87 patients.
Results
Patients were classified into 2 groups, sur-
vivors (34 patients, 36.2%) and non-survivors 
(60 patients, 63.8%) according to 30 day mortality. 
With regards to demographic data, there was a sig-
nificant difference between both groups regarding 
age; survivors were younger than non-survivors 
(p = 0.045). The same, however, was not true with 
regards to sex and the cause of ARDS (p = 0.092, 
0.261 respectively). The arterial blood gases 
significantly differed between both groups with 
survivors having a higher pH (p < 0.001), a lower 
PaCO2 (p < 0.001), and a lower HCO3 (p = 0.013) 
as compared to non-survivors. The PaO2/FiO2 ratio 
was significantly lower in the non-survivor group 
compared with the survivor group (p = 0.006). 
There was a significant difference between the 
two groups in terms of ARDS classification (p = 
0.025) and APACHE II score as it was lower in sur-
vivors than non-survivors (p < 0.001) (Table 1).
Regarding the ventilatory parameters in both 
groups, there were a significant difference with 
regards to PEEP and plateau and driving pressures 
(p < 0.001). Survivors had lower days of mechan-
ical ventilation compared to non-survivors (3.0 vs 
7.5 days, respectively; p = 0.001). Also, survivors 
had a lower length of ICU stay in comparison to 
non-survivors (5.0 vs 8.0 days, respectively; p = 
0.001) (Table 1). 
Regarding the right ventricular function 
parameters survivors had a higher RV-FAC com-
pared to non-survivors (57.91 ± 12.89 vs 41.88 ± 
11.70%, respectively; p < 0.001). TAPSE was 
significantly higher in survivors in comparison to 
non-survivors (20.91 ± 3.79 vs 14.12 ± 3.22 mm, 
respectively; p < 0.001). Survivors had a lower 
SPAP than non-survivors (46.76 ± 6.73 vs 54.65 ± 
7.25 mm Hg, respectively; p < 0.001). Also, survi-
vors had a lower Tei index compared to non-sur-
vivors (45.15 ± 4.48 vs 51.67 ± 5.02, respectively; 
p < 0.001) (Table 1).
The right ventricular function parameters 
were analyzed according to their correlation with 
the severity of ARDS in terms of PaO2/FiO2 ratio, 
days of mechanical ventilation, and length of ICU 
stay. PaO2/FiO2 ratio and length of ICU stay were 
significantly correlated with RV-FAC, Tei index, 
and TAPSE, while the length of mechanical ven-
tilation days was significantly correlated with the 
Tei index only (Table 2).
The association of the echocardiographic pa-
rameters of the right ventricle with mortality was 
further assessed with a logistic regression model 
using age, PaO2/FiO2 ratio, PEEP, RV-FAC, SPAP, Tei 
index, and TAPSE. Univariate analysis revealed 
that age, PaO2/FiO2 ratio, PEEP, RV-FAC, SPAP, Tei 
index, and TAPSE were associated with increased 
hospital mortality in ARDS. Multivariate regres-
sion was analyzed to determine which parame-
ters were independently related to mortality and 
revealed that TAPSE (p = 0.004), Tei index (p = 
0.006), and PEEP (p = 0.036) were independently 
associated with mortality (Table 3).
The ROC curve was used to test the right ven-
tricular function parameters, PaO2/FiO2 ratio, and 
APACHE II score to predict mortality as shown 
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Table 1. Comparison between survivors and non-survivors of ARDS regarding baseline characteristics and right ventricular 
function parameters





Age[years] (mean ± SD) 50.88 ± 14.99 57.2 ± 13.28 0.045
Sex [n%]
   Male






Cause of ARDS [n%]
   Pulmonary causes
   Pneumonia
   Lung contusions
   Drowning
   Extra pulmonary causes
   Pancreatitis
   Intra-abdominal sepsis














Diabetes mellitus [n%] 5 (14.7) 10 (16.6) 0.803
Hypertension [n%] 2 (5.8) 3 (5) FEp=1.00
Chronic kidney disease [n%] 3 (8.8) 6 (10) FEp=1.00
Liver failure [n%] 1(2.9) 2(3.3) FEp=1.00
Shock [n%] 4 (11.8) 9 (15) FEp=1.00
APACHE II (mean ± SD) 14.76 ± 4.60 42.57 ± 12.22 < 0.001
PaO2/FiO2 ratio (mean ± SD) 150.0 ± 42.69 123.1 ± 46.19 0.006
ARDS classification [n%]
   Mild 
   Moderate 








pH (mean ± SD) 7.43 ± 0.04 7.30 ± 0.05 < 0.001
PaCO2 [mm Hg] (mean ± SD) 32.62 ± 3.03 47.52 ± 6.29 < 0.001
HCO3 [mEq/L] (mean ± SD) 22.79 ± 2.28 23.83 ± 1.66 0.013
Plateau pressure [cmH2O] (mean ± SD) 27.06 ± 5.67 34.03 ± 4.03 < 0.001
PEEP [cmH2O] (mean ± SD) 12.18 ± 2.70 14.43 ± 2.34 < 0.001
Driving pressure [cmH2O] (mean ± SD) 14.68 ± 4.92 19.52 ± 4.40 < 0.001
Days of MV 
min.–max. (median) 1.0 – 9.0 (3) 1.0 – 10.0 (7.5) 0.001
Length of ICU stay
min.–max. (median) 3.0 – 11.0 (5) 3.0 – 10.0 (8) 0.001
RV-FAC [%] (mean ± SD) 57.91 ± 12.89 41.88 ± 11.70 < 0.001
SPAP [mm Hg] (mean ± SD) 46.76 ± 6.73 54.65 ± 7.25 < 0.001
Tei index (MPI) (mean ± SD) 45.15 ± 4.48 51.67 ± 5.02 < 0.001
TAPSE [mm] (mean ± SD) 20.91 ± 3.79 14.12 ± 3.22 < 0.001
P: p value for comparing between the two studied groups, statistically significant at p ≤ 0.05 (Boldface type).
APACHE II — Acute Physiology Age Chronic Health Evaluation II; ARDS — acute respiratory distress syndrome; HCO3 — serum bicarbonate; MV — mechanical 
ventilation; PaCO2 — partial pressure of carbon dioxide; PEEP — positive end expiratory pressure; RV-FAC — right ventricle fractional area change; SPAP — systolic 
pulmonary artery pressure; TAPSE — tricuspid annular plane systolic excursion; Tei index (MPI) — myocardial performance index
in Figure 1. It became clear that the APACHE II 
score with a cutoff point < 24 had the highest 
sensitivity and specificity to predict mortality 
in ARDS (AUC 0.984; 95% CI 0.959–1.009) with 
p < 0.001. Regarding right ventricular function 
parameters, we found that RV-FAC with a cutoff 
point ≤ 57% had the highest sensitivity to predict 
mortality (AUC 0.825; 95% CI 0.732–0.918) with 
p < 0.001, followed by Tei index with a cutoff 
point > 47 (AUC 0.844; 95% CI 0.765–0.922) with 
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Table 2. Correlation between right ventricular function parameters with PaO2/FiO2 ratio, mechanical ventilation days, and 
length of ICU stay 
Parameters of right 
ventricular function
PaO2/FiO2 ratio Mechanical ventilation days Length of ICU stay
r p r p r p
RV-FAC 0.292 0.004 -0.083 0.427 -0.255 0.013
SPAP -0.146 0.160 0.048 0.643 0.117 0.260
Tei index (MPI) -0.256 0.013 0.424 < 0.001 0.274 0.007
TAPSE 0.232 0.025 -0.182 0.079 -0.309 0.002
R: Pearson coefficient, statistically significant at p ≤ 0.05 (Boldface type).
ICU — intensive care unit; RV-FAC — right ventricle fractional area change; SPAP — systolic pulmonary artery pressure; TAPSE — tricuspid annular plane systolic 
excursion; Tei index (MPI) — myocardial performance index
Table 3. Univariate and multivariate analysis of the parameters affecting mortality
Univariate Multivariate
P OR (95%CI) p OR (95%CI)
PaO2/FiO2 ratio 0.009 0.987 (0.978–0.997) 0.966 1.001 (0.974–1.028)
PEEP < 0.001 1.436 (1.180–1.748) 0.036 2.030 (1.047–3.935)
RV-FAC < 0.001 0.901 (0.862–0.942) 0.138 0.892 (0.767–1.037)
SPAP < 0.001 1.180 (1.090–1.276) 0.054 1.424 (0.994–2.039)
Tei index (MPI) < 0.001 1.31 (1.167–1.477) 0.006 1.796 (1.187–2.718)
TAPSE < 0.001 0.631 (0.532–0.750) 0.004 0.396 (0.211–0.741)
Age 0.041 1.032 (1.001–1.065) 0.110 1.081 (0.983–1.189)
#: all variables with p < 0.05 was included in the multivariate, statistically significant at p ≤ 0.05 (Boldface type).
CI — confidence interval; OR — odd’s ratio; RV-FAC — right ventricle fractional area change; SPAP — systolic pulmonary artery pressure; TAPSE — tricuspid annular 
plane systolic excursion; Tei index (MPI) — myocardial performance index
Figure 1. ROC curve for right ventricular function parameters, APACHE II score, and PaO2/FiO2 ratio (HI) to predict mortality in ARDS
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Table 4. Agreement (sensitivity, specificity) for right ventricular function parameters, APACHE II score, and PaO2/FiO2 ratio 
to predict mortality in ARDS 
AUC P 95% CI Cut off Sensitivity Specificity PPV NPV
APACHE II 0.984 < 0.001 0.959–1.009 >24 95.00 97.06 98.3 91.7
TAPSE 0.904 < 0.001 0.844–0.964 ≤ 17 83.33 82.35 89.3 73.7
Tei index 0.844 < 0.001 0.765–0.922 > 47 85.0 67.65 82.3 71.9
RV-FAC 0.825 < 0.001 0.732–0.918 ≤ 57 91.67 64.71 82.1 81.5
SPAP 0.789 < 0.001 0.695–0.884 > 50 73.33 70.59 81.5 60.0
PaO2/FiO2 ratio 0.708 0.001 0.605–0.812 ≤ 124 68.33 76.47 83.7 57.8
Statistically significant at p ≤ 0.05 (Boldface type). 
APACHE II — Acute Physiology Age Chronic Health Evaluation II; ARDS — acute respiratory distress syndrome; AUC — area under a curve; CI — confidence Intervals; 
MPI — myocardial performance index; p value — probability value; RV-FAC — right ventricle fractional area change; SPAP — systolic pulmonary artery pressure; 
TAPSE — tricuspid annular plane systolic excursion; 
p < 0.001. TAPSE, with a cutoff point ≤ 17 mm, 
was the most specific right ventricular function 
parameter to predict mortality (AUC 0.904; 95% 
CI 0.844–0.964) with p < 0.001, followed by SPAP 
with a cutoff point >50 mm Hg (AUC 0.789; 95% 
CI 0.695–0.884) with p < 0.001 (Table 4).
Discussion
Regarding demographic data of the patients, 
we found a significant difference between both 
groups with regards to age which was similar to 
the study by Balzer et al. who studied predictors 
of survival in ARDS [17].
In our study, ABG parameters differed signifi-
cantly between both groups. In the study by Shah 
et al., they found a significant difference only 
with regards to pH, which they explained as being 
a result of their small sample size which limited 
the ability of their study to reveal the differences 
among other parameters [18]. Similarly to our 
study, Osman et al., who studied the prognosis 
of right ventricular failure in ARDS in a larger 
sample size than Shah et al., found significant 
differences between both groups regarding pH 
and PaCO2 [19]. 
We found significant differences between 
survivors and non-survivors with regards to 
PaO2/FiO2 ratio and APACHE II score. These re-
sults were also found in the studies completed by 
Shah et al. and Osman et al. [18–19]. Our results 
were similar to the LUNG SAFE study, which 
was performed in 459 ICUs in 50 countries, with 
regards to age, sex, etiology of ARDS, pH, and 
PaO2/FiO2 ratio [20].
In our study, we found significant differences 
between both studied groups regarding plateau, 
driving pressures, and PEEP. Claude Guerin et al., 
who studied the driving pressure effect on mor-
tality in ARDS patients, also found that plateau 
and driving pressures were significantly different 
between survivors and non-survivors [21]. Also, 
Amato et al. found that driving pressure was most 
strongly associated with survival [22]. However, 
that was not found in the study conducted by 
Shah et al. as they did not find any significant 
difference with regards to ventilatory param-
eters between the studied groups. Again, they 
explained this result as a drawback of their small 
sample size [18].
Regarding the indices of right ventricular 
function, our study showed that survivors and 
non-survivors differed significantly with regards 
to TAPSE, Tei index, RV-FAC, and SPAP. In 2 stud-
ies by Shah et al. and Wadia et al., they found 
a significant difference between survivors and 
non-survivors with regards to TAPSE only. This 
may be due to the sample size of their studies 
and due to the fact that they did not assess the 
parameters in all patients due to a poor echocar-
diographic window which was part of the exclu-
sion criteria in our study [18, 23]. In another study 
by Adi Aran et al. who evaluated the prognostic 
value of echocardiography in pediatric ARDS, 
they found a higher mortality rate in patients with 
right ventricular dysfunction defined by RV-FAC 
less than 45% [24].
Our study showed that the PaO2/FiO2 ratio 
significantly correlated with RV-FAC, Tei index, 
and TAPSE. This was a similar finding in the Adi 
Aran et al. study which found a significant cor-
relation between PaO2/FiO2 ratio and TAPSE and 
Tei index, respectively [24]. Also, the significant 
correlation between PaO2/FiO2 ratio and RV-FAC 
was found in a meta-analysis by Justin Lee et 
al. who concluded that acute hypoxemia mostly 
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affects systolic function of the right ventricle, 
which is accurately estimated with RV-FAC [25]. 
Meanwhile, there was no significant correlation 
between PaO2/FiO2 ratio and SPAP, and this could 
be explained by the pathophysiology of hypox-
emia-associated pulmonary hypertension which 
is caused by vascular remodeling rather than hy-
poxemia-induced arterial narrowing. This results 
in SPAP being elevated only after a significant 
period of time [26]. 
We found a significant correlation between 
the length of ICU stay with TAPSE and RV-FAC. 
Gajanana et al. studied the association between 
TAPSE and mortality in the ICU and found a cor-
relation between a prolonged ICU stay and low 
TAPSE [27]. Also, Vallabhajosyula et al. found that 
a RV-FAC less than 35% was associated with a pro-
longed ICU stay in comparison with normal right 
ventricular function in septic patients [28]. Also, 
we found a significant correlation between the Tei 
index and the duration of mechanical ventilation. 
Similarly, El Ashmawy et al., who studied the 
role of the Tei index in the prediction of weaning 
failure in COPD patients, found higher Tei index 
values in patients with failed weaning [29].
Multivariate regression analysis found that 
TAPSE, Tei index, and PEEP were significant inde-
pendent factors of mortality. Shah et al. found that 
TAPSE was the only independent factor associat-
ed with mortality and this could be explained by 
their small sample size [19]. We tested agreement 
for the right ventricular function parameters to 
predict mortality and found that TAPSE < 17 mm 
had the highest specificity (82.35%), and that 
RV-FAC had the highest sensitivity (91.67%). In 
a study by Tamborini et al. involving 750 patients 
with various heart diseases, a TAPSE value of 
< 17 mm was highly specific for right ventricular 
dysfunction but had very low sensitivity [30]. 
Also, Shah et al. found that non-survivors had 
a TAPSE value of < 17 mm (upper limit of 95% 
confidence interval: 16.77 mm) [19].
Limitation of the study
Larger sample size studies are needed to 
increase the power of the study and limit the 
margin of error. Multicenter studies are needed 
to improve the external validity and support wide 
changes in practice.
Conclusions
Transthoracic echocardiographic parameters 
of the right ventricle could be used to predict 
mortality in patients with ARDS with high sen-
sitivity and specificity. 
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